David Roche of Quantum Strategy says a weaker dollar will drive 10-year yields to 5.5%, which will threaten the dollar's ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere ...

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.